Full Text
Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy

Abstract

Authors

N Kragh E Ye WJ Valentine B Hunt

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×